One shot to shield kids from malaria? new antibody shows promise
NCT ID NCT05400655
Summary
This study tested a one-time injection of an experimental antibody called L9LS to see if it could safely protect children from getting malaria. Over 900 healthy children in Kenya, where malaria is common, received either the antibody or a placebo shot. Researchers monitored the children for up to a year to check for side effects and to see if the antibody prevented malaria infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kenya Medical Research Institute (KEMRI) Center for Global Health Research (CGHR)
Kisumu, Kenya
Conditions
Explore the condition pages connected to this study.